Newsletters
Technology, Discovery & Innovation NewsFactor Sites:       NewsFactor.com     Enterprise Security Today     CRM Daily     Business Report     Sci-Tech Today  
   
This ad will display for the next 20 seconds. Please click for more information, or scroll down to pass the ad, or Close Ad.
Home Computing Digital Life Discovery Space More Topics...
Eliminate costly downtime!
Find out how with Free White Paper
& enter to win a Samsung Galaxy Note

www.apc.com
Science News
Average Rating:
Rate this article:  
Merck Joins Companies Ending Chimpanzee Research
Merck Joins Companies Ending Chimpanzee Research

By The Associated Press
January 31, 2014 9:59AM

Bookmark and Share
Top pharmaceutical companies, including Merck, are phasing out chimpanzee research, amid improved technology, animal alternatives and pressure from animal rights groups, the NIH and Congress. Technology now allows researchers to do initial testing via computer simulations, in bacteria or cells, and in animals as small as fish.
 



Drugmaker Merck & Co. is joining two dozen other pharmaceutical companies and contract laboratories in committing to not use chimpanzees for research.

The growing trend could mean roughly 1,000 chimps in the U.S. used for research or warehoused for many years in laboratory cages could be "retired" to sanctuaries by around 2020.

That's according to Kathleen Conlee of the Humane Society of the United States, which seven years ago began urging companies to phase out all chimp research.

The trend is driven by improved technology, animal alternatives and pressure from animal rights groups, the National Institutes of Health and Congress.

Last June, reacting to an Institute of Medicine study Congress had requested that concluded nearly all chimp research is unnecessary, the NIH announced it would retire and send about 90 percent of government-owned research chimps to the Chimp Haven sanctuary in Keithville, La. It's now home to about 160 chimps, with nearly 60 more to arrive soon.

After several years, the NIH plans to decide whether the remaining chimps in government labs can also be moved to sanctuaries. Roughly 450 other chimps are owned by private labs that do research under contract for drugmakers and other companies.

"It's been a long road in trying to end the use of chimpanzees in research, and we're now at a turning point," Conlee told The Associated Press Thursday. "We're going to keep on (advocating) until the chimpanzees in laboratories are all in sanctuaries."

Merck spokeswoman Caroline Lappetito said the company, based in Whitehouse Station, N.J., decided late last year to stop research on chimpanzees and switch to alternative types of testing.

"The science has advanced, and we don't really need it," Lappetito said.

Merck, the world's third-biggest drugmaker, is the largest to make the switch.

Companies that develop medicines and consumer products such as cosmetics have long used animals to test safety and effectiveness. In the case of experimental medicines, drugmakers must test on animals before the Food and Drug Administration will let them do the human testing needed for approval of a new therapy.

Nearly all animal experiments in the U.S. involve mice, rats and guinea pigs, although some are done on dogs and great apes, almost always chimpanzees.

But animal research, particularly on primates and pet species such as dogs and rabbits, has long drawn criticism from animal rights groups, including protests outside laboratories and at annual shareholder meetings. Besides calling the practice inhumane, activists often have alleged -- and sometimes proven -- that animals were being abused.

Many companies previously said it was necessary to test potential medicines and vaccines on nonhuman primates because they needed an animal in which the anatomy and disease course were very similar to that in humans.

That thinking changed as technology allowed researchers to do initial testing via computer simulations, in bacteria or cells, and in animals as small as fish. Many drugmakers also found ways to do testing on far fewer animals and to limit the discomfort of experiments by using painkillers and tranquilizers. And many of the companies pledging not to use chimps in the future never did so.

British drugmaker GlaxoSmithKline PLC was one of the first to stop research in chimps, back in 2008.

"Research we did on nonhuman primates was kept to a minimum" even before that, said spokeswoman Melinda Stubee.

Because chimpanzees used for commercial medical research generally are confined in the labs of contract testing companies, Conlee said the Humane Society is trying to convince them that there's no longer enough demand to continue warehousing chimpanzees for potential future work. She hopes they'll pay to support those chimpanzees in one of five U.S. accredited sanctuaries for former research chimps.
 


© 2014 Associated Press/AP Online under contract with NewsEdge. All rights reserved.
 

Tell Us What You Think
Comment:

Name:

Just ONE voice:

Posted: 2014-02-19 @ 4:06am PT
Just ONE voice for the voiceless .... joining thousands and thousands of others:

I can't tell you what I think because I'm crying with joy! I'm one of those dedicated activists who demonstrated and marched and begged ALL of the companies to stop research on ALL primates .... and, ALL ANIMALS! This is just the first step, until they also cease and find alternatives for other animals used in experimentation. We finally got through to them, and they lied for years and years and said they needed them. The proof is in this development! But,if they think activists will go away now, they have another thing coming. There are many more species for which experiments must end. Our job is no where near finished yet ..... there's much more to come. Get ready for larger and larger demonstrations and more and more demands made on the experimenters. Many are becoming too ashamed to even admit they do vivisection on animals, and they're becoming more hated every day. Why? Because there's nothing they can do for humans by studying animals! This is a giant first step. Keep informed on the subject and you'll come to see.



APC has an established a reputation for solid products that virtually pay for themselves upon installation. Who has time to spend worrying about system downtime? APC makes it easy for you to focus on business growth instead of business downtime with reliable data center systems and IT solutions. Learn more here.


 Science News
1.   Triggering Resilience to Depression
2.   DNA Pap Smear Alternative Debated
3.   Full Lunar Eclipse Delights Americas
4.   Jet Lag? There's an App for That
5.   3-D Printer Bid To Build Human Heart


advertisement
WHO: Pollution Kills 7 Million Yearly
Now biggest environmental health risk.
Average Rating:
DNA Pap Smear Alternative Debated
Women's groups fear overtreatment.
Average Rating:
3-D Printer Bid To Build Human Heart
Finished product called bioficial heart.
Average Rating:


advertisement


 Random Bytes
Triggering Resilience to Depression Jet Lag? There's an App for That
Full Lunar Eclipse Delights Americas DNA Pap Smear Alternative Debated
Product Information and Resources for Technology You Can Use To Boost Your Business

Network Security Spotlight
Heartbleed Could Cost Millions, Could Have Been Prevented
Early estimates of Heartbleed’s cost to enterprises are running in the millions. The reason: revoking all the SSL certificates the bug exposed will come at a very hefty price. Some say it all could have been avoided.
 
Michaels Says Nearly 3M Credit, Debit Cards Breached
Arts and crafts retail giant Michaels Stores has confirmed that a data breach at its POS terminals from May 2013 to Jan. 2014 may have exposed nearly 3 million customer credit and debit cards.
 
Google's Street View Software Unravels CAPTCHAs
The latest software Google uses for its Street View cars to read street numbers in images for Google Maps works so well that it also solves CAPTCHAs, those puzzles designed to defeat bots.
 

Enterprise Hardware Spotlight
Vaio Fit 11A Battery Danger Forces Recall by Sony
Using a Sony Vaio Fit 11A laptop? It's time to send it back to Sony. In fact, Sony is encouraging people to stop using the laptop after several reports of its Panasonic battery overheating.
 
Continued Drop in Global PC Shipments Slows
Worldwide shipments of PCs fell during the first three months of the year, but the global slump in PC demand may be easing, with a considerable slowdown from last year's drops.
 
Google Glass Finds a Home in Medical Education, Practice
The innovative headpiece may find its niche in markets where hands-free access to data can be a big advantage. Glass experiments for doctors are already under way, with some promising results.
 

Mobile Technology Spotlight
Review: Siri-Like Cortana Fills Windows Phone Gap
With the new Cortana virtual assistant, Windows catches up with Apple's iOS and Google's Android in a major way, taking some of the best parts of Apple's and Google's virtual assistants, with new tools too.
 
With Galaxy S5, Samsung Proves Less Can Be More
Samsung has produced the most formidable rival yet to the iPhone 5s: the Galaxy S5. The device is the fifth edition of the company's successful line of Galaxy S smartphones, and shows less can be more.
 
Facebook Rolls Out Potentially Intrusive Location-Sharing
Looking for friends? Facebook users in the U.S. will soon be able to see which of their friends are nearby, using a smartphone's GPS. Could be a cool feature in some cases, or way too much information.
 

Navigation
Sci-Tech Today
Home/Top News | Computing | Digital Life | Discovery | Space | Innovation | Health | Science News
Environment
NewsFactor Network Enterprise I.T. Sites
NewsFactor Technology News | Enterprise Security Today | CRM Daily

NewsFactor Business and Innovation Sites
Sci-Tech Today | NewsFactor Business Report

NewsFactor Services
FreeNewsFeed | Free Newsletters | XML/RSS Feed

About NewsFactor Network | How To Contact Us | Article Reprints | Careers @ NewsFactor | Services for PR Pros | Top Tech Wire | How To Advertise

Privacy Policy | Terms of Service
© Copyright 2000-2014 NewsFactor Network. All rights reserved. Article rating technology by Blogowogo. Member of Accuserve Ad Network.